Protein-C deficiency presenting as pulmonary embolism and myocardial infarction in the same patient

Syed Maqbool1, Vishal Rastogi, Ashok Seth

  • 1Invasive Cardiology, Fortis Escorts Heart Institute, New Delhi 110025, India. syedmaqbool20@yahoo.com.

Thrombosis Journal
|November 16, 2013
PubMed

Insights

Protein C deficiency, a hereditary condition, increases risk for blood clots. This case highlights that even arterial clots like myocardial infarction can occur in young patients with this deficiency, suggesting broader implications for thrombotic risk assessment.

Area of Science:

  • Cardiology
  • Hematology
  • Genetics

Background:

  • Plasma protein C is a crucial anticoagulant, inactivating factors V and VIII.
  • Hereditary protein C deficiency, an autosomal dominant disorder, predisposes individuals to thrombotic events.
  • While venous thrombosis is well-established, arterial thrombosis in protein C deficiency remains debated.

Observation:

  • A young patient with heterozygous protein C deficiency presented with both pulmonary embolism and myocardial infarction.
  • The patient had no other significant underlying risk factors for thrombosis.
  • This clinical presentation challenges the traditional understanding of protein C deficiency's thrombotic spectrum.

Findings:

  • Congenital heterozygous protein C deficiency can manifest as arterial thrombosis, specifically myocardial infarction.
  • This case suggests that protein C deficiency should be considered in young individuals experiencing arterial thrombotic events without apparent risk factors.
  • The anticoagulatory role of protein C is critical in preventing both venous and arterial thrombotic occlusions.

Implications:

  • Evaluating young patients with myocardial infarction for protein C deficiency may lead to earlier diagnosis and management.
  • This finding broadens the scope of clinical suspicion for protein C deficiency beyond venous thromboembolism.
  • Further research is warranted to elucidate the precise mechanisms linking protein C deficiency to arterial thrombosis.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
65
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
760
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
950
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957